Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod Ruchika Sharma18 May 2024 2:30 PM ISTMumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a...
A tailored vaccine could one day treat eczema in children-new research Dr. Kamal Kant Kohli17 May 2024 8:45 PM ISTNew research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven...
Groundbreaking study shows novel peel combination as safe and effective for hand lentigines Medha Baranwal16 May 2024 8:00 PM ISTUSA: In a groundbreaking study published in Dermatologic Surgery, dermatologists have unveiled a promising new treatment for hand lentigines, or age...
Nemolizumab and topical steroid combination effective against prurigo nodularis: Study Jacinthlyn Sylvia15 May 2024 10:00 PM ISTA recent study from Japan unveiled promising outcomes in the stride to effectively manage Prurigo Nodularis (PN) which is a chronic inflammatory skin...
Which is better local anesthesia technique for mesotherapy for Hair Regrowth in the Temporal Region? Dr Monish Raut14 May 2024 8:00 PM ISTRecently published research paper investigates the efficacy of mesotherapy for hair regrowth in the temporal region, specifically focusing on the use...
Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma Ruchika Sharma14 May 2024 4:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...
Study explores potential of oral melatonin in treating stubborn melasma Medha Baranwal14 May 2024 10:15 AM ISTIndia: Melasma, a common skin condition characterized by hyperpigmentation, has long been a challenge to treat effectively. However, a recent study...
Zydus Lifesciences Dexamethasone Tablets bags USFDA okay Ruchika Sharma13 May 2024 11:22 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
Higher number of biologics required for control of coexisting PsA and atopic dermatitis: Study Jacinthlyn Sylvia13 May 2024 6:45 AM ISTA recent study published in the Journal of Personalized Medicine observed new insights regarding the treatment of psoriatic arthritis (PsA) and its...
Ruxolitinib Cream Shows Promise in Treating Adolescent Atopic Dermatitis: Study Medha Baranwal10 May 2024 9:30 PM ISTUSA: In a groundbreaking development in dermatology, the efficacy, safety, and long-term disease control of Ruxolitinib Cream among adolescents with...
Both targeted and whole-body NB-UVB are effective treatment options for acral vitiligo patients: Study Medha Baranwal9 May 2024 8:30 PM ISTIndia: In a groundbreaking development in acral vitiligo treatment, a split-body randomized controlled trial has demonstrated the efficacy of...
Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment Ruchika Sharma9 May 2024 2:52 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...
